Sekalala, Sharifah (2010) Third world access to essential medicines and the WTO general council decision of 2003. King's Law Journal, 21 (1). pp. 172-192. doi:10.1080/09615768.2010.11423699 ISSN 0961-5768.

Research output not available from this repository.

Request-a-Copy directly from author or use local Library Get it For Me service.

Request Changes to record.

Abstract

Following the Implementation of Paragraph 6 of the Doha Declaration on TRIPS and public health, Canada was the first developed country to amend its patent law, which resulted in Canada's Access to Medicines Regime (CAMR). The CAMR allowed manufacturers to manufacture generic drugs domestically and export them to developing countries with insufficient manufacturing capacity. This paper uses the case of Rwanda, which was the first developing country to take advantage of this legislation, in order to analyse how effective the CAMR and the Paragraph 6 Agreement were in ensuring that developing countries could access generic drugs.

Item Type:	Journal Article
Subjects:	D History General and Old World > DT Africa K Law [LC] > KE Canada R Medicine > RA Public aspects of medicine R Medicine > RM Therapeutics. Pharmacology R Medicine > RS Pharmacy and materia medica
Divisions:	Faculty of Social Sciences > School of Law
Library of Congress Subject Headings (LCSH):	Patent medicines--Law and legislation--Canada, Generic drugs--Law and legislation--Canada, Pharmaceutical policy--Canada, Medical care--Rwanda--Costs
Journal or Publication Title:	King's Law Journal
Publisher:	Hart Publishing Ltd.
ISSN:	0961-5768
Official Date:	February 2010
Dates:	Date Event February 2010 Published
Volume:	21
Number:	1
Page Range:	pp. 172-192
DOI:	10.1080/09615768.2010.11423699
Status:	Peer Reviewed
Publication Status:	Published
Access rights to Published version:	Restricted or Subscription Access

Request changes or add full text files to a record

Repository staff actions (login required)

View Item